KEVIN MAINZ: Open Payments
NPI 1205130853 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,043 in 68 payments from 19 companies in 2025. Trend: 2023 $3,440 · 2024 $3,111 · 2025 $2,043
Food & beverage: $1,944Education: $99
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 8 | $628 |
| Novartis Pharmaceuticals Corporation | 16 | $288 |
| Merck Sharp & Dohme LLC | 11 | $244 |
| HEARTFLOW, INC. | 5 | $159 |
| Actelion Pharmaceuticals US, Inc. | 1 | $99 |
| Novo Nordisk Inc | 5 | $87 |
| E.R. Squibb & Sons, L.L.C. | 2 | $87 |
| ABIOMED | 2 | $66 |
| Boston Scientific Corporation | 3 | $64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $58 |
Products named: LEQVIO, ASSURITY, VERQUVO, FFRct, AMPLATZER AMULET, MITRACLIP, MERLIN@HOME, OPSUMIT.
Industry payments across TX — which companies pay providers there.
